CapitalG invested in the no-code app software provider at a $2.1bn valuation more than five times higher than it was 18 months ago.

Intel Capital chipped in as part of a series B round set to drive product development and growth for food supply insights provider Gro Intelligence.

The Sinopharm and WuXi AppTec-backed, complement system-focused drug developer has hauled in $53.3m of new funding after emerging from stealth late last year.

The cardiovascular treatment device developer raised about $46m in a round led by Tencent and has now secured roughly $60m altogether.

Fivestar Holdings took part in a series B round for the early education platform developer through investment vehicle Focustar Capital.

American Family’s venture capital unit has contributed to a $22.5m round that will support the digital mortgage lender's US expansion.

Genomic drug developer Tessera Therapeutics raised $230m in a round co-led by SoftBank Vision Fund 2 as it works on its gene writing technology.

LifeMine’s chairman and co-founder Rick Klausner has co-led a round that included multiple corporates and pushed the overall equity to $120m.

Lilly Asia Ventures has led a $23.2m round for the digital diagnostics technology developer, investing alongside new and existing backers.

Cambrian Biopharma returned to back the immunotherapy developer's series B round, following its series A three months ago.